180 related articles for article (PubMed ID: 20558936)
1. A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
Matsuda T; Koreeda Y; Mataki H; Taira T; Noma S; Higashimoto I
Intern Med; 2010; 49(12):1163-9. PubMed ID: 20558936
[TBL] [Abstract][Full Text] [Related]
2. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Kohno S; Izumikawa K; Ogawa K; Kurashima A; Okimoto N; Amitani R; Kakeya H; Niki Y; Miyazaki Y;
J Infect; 2010 Nov; 61(5):410-8. PubMed ID: 20797407
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
[No Abstract] [Full Text] [Related]
4. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of Aspergillus empyema using combined intrathoracic and intravenous administration of voriconazole: A case report.
Takatsuka H; Yamazaki S; Watanabe A; Yokoyama I; Suzuki T; Kamei K; Ishii I
J Infect Chemother; 2020 Aug; 26(8):847-850. PubMed ID: 32414688
[TBL] [Abstract][Full Text] [Related]
6. Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report.
Almuhareb A; Habib Z
J Infect Public Health; 2018; 11(2):280-282. PubMed ID: 28545901
[TBL] [Abstract][Full Text] [Related]
7. Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Yu J; Mu X; Li R
J Clin Microbiol; 2013 Apr; 51(4):1327-9. PubMed ID: 23363828
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
[TBL] [Abstract][Full Text] [Related]
9. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
Stern JB; Girard P; Caliandro R
Antimicrob Agents Chemother; 2004 Mar; 48(3):1065. PubMed ID: 14982812
[No Abstract] [Full Text] [Related]
10. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Clemons KV; Schwartz JA; Stevens DA
Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
[TBL] [Abstract][Full Text] [Related]
11. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
12. Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Ouchi H; Fujita M; Ikegame S; Inoshima I; Harada E; Nakanishi Y
J Infect Chemother; 2007 Aug; 13(4):258-62. PubMed ID: 17721689
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
Hashimoto M; Honda Y; Fujishima T
Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):957-61. PubMed ID: 18186242
[TBL] [Abstract][Full Text] [Related]
14. Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
Zhao Y; Paderu P; Park S; Dukhan A; Senter M; Perlin DS
Antimicrob Agents Chemother; 2012 May; 56(5):2770-2. PubMed ID: 22314535
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
Zhang M; Su X; Sun WK; Chen F; Xu XY; Shi Y
Mycopathologia; 2014 Feb; 177(1-2):11-8. PubMed ID: 24306184
[TBL] [Abstract][Full Text] [Related]
16. In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions.
Fakhim H; Vaezi A; Dannaoui E; Sharma C; Mousavi B; Chowdhary A; Meis JF; Badali H
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):266-268. PubMed ID: 29622284
[TBL] [Abstract][Full Text] [Related]
17. Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.
Réminiac F; Sonneville R; Massias L; Chochillon C; Wolff M
Antimicrob Agents Chemother; 2014 Jun; 58(6):3568-9. PubMed ID: 24733459
[No Abstract] [Full Text] [Related]
18. Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Björkholm M; Kalin M; Grane P; Celsing F
Infection; 2012 Feb; 40(1):81-5. PubMed ID: 21779887
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
20. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
